BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 11197301)

  • 21. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression.
    Knudsen TB; Kristiansen TB; Katzenstein TL; Eugen-Olsen J;
    J Med Virol; 2001 Nov; 65(3):441-4. PubMed ID: 11596075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
    Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
    J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
    Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA
    J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Polymorphisms of chemokine receptor alleles influencing genetic susceptibility to HIV-1 infection in Mongolia population in China].
    Du Q; Wang F; Hong W; Liu M; Jin L; Shi H; Lei Z; E E
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):413-6. PubMed ID: 11860823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression.
    Tang J; Rivers C; Karita E; Costello C; Allen S; Fultz PN; Schoenbaum EE; Kaslow RA
    Genes Immun; 1999 Sep; 1(1):20-7. PubMed ID: 11197301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progression.
    Paxton WA; Kang S
    Semin Immunol; 1998 Jun; 10(3):187-94. PubMed ID: 9653045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Polymorphism of human alleles associated with genetic resistance against HIV-1 infection and its implications].
    Wang F; Liu D
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):285-7. PubMed ID: 10932017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele.
    McNicholl JM; Smith DK; Qari SH; Hodge T
    Emerg Infect Dis; 1997; 3(3):261-71. PubMed ID: 9284370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic determinant factors of resistance to HIV infection and of control of progression to AIDS: implications on pathogenesis and therapeutic approaches for the eradication of HIV. A review].
    Zúñiga J; Vargas-Alarcón G; Salgado N; Flores C; Martínez-Tripp S; Miranda A; Balbuena A; Osnaya N; Juárez F; Granados J; Reyes-Terán G
    Rev Invest Clin; 2000; 52(3):284-95. PubMed ID: 10953612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host genetic influences on HIV-1 pathogenesis.
    Michael NL
    Curr Opin Immunol; 1999 Aug; 11(4):466-74. PubMed ID: 10448150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences.
    Carrington M; Dean M; Martin MP; O'Brien SJ
    Hum Mol Genet; 1999; 8(10):1939-45. PubMed ID: 10469847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolutionary history of the CCR5-Delta32 HIV-resistance mutation.
    Galvani AP; Novembre J
    Microbes Infect; 2005 Feb; 7(2):302-9. PubMed ID: 15715976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of host genes on HIV-1 disease progression.
    Roger M
    FASEB J; 1998 Jun; 12(9):625-32. PubMed ID: 9619442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Are prehistoric epidemics reflected in the genetic variability of Danes and in current pathogenesis of HIV infections?].
    Eugen-Olsen J; Møller-Jensen A; Nielsen JO
    Ugeskr Laeger; 1998 Dec; 160(52):7585-8. PubMed ID: 9889676
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV types, groups, subtypes and recombinant forms: errors in replication, selection pressure and quasispecies.
    Eberle J; Gürtler L
    Intervirology; 2012; 55(2):79-83. PubMed ID: 22286874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Considering genetic profiles in functional studies of immune responsiveness to HIV-1.
    Carrington M; Nelson G; O'Brien SJ
    Immunol Lett; 2001 Nov; 79(1-2):131-40. PubMed ID: 11595300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic determinants of HIV-1 infection and its manifestations.
    Kaslow RA; McNicholl JM
    Proc Assoc Am Physicians; 1999; 111(4):299-307. PubMed ID: 10417737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of host genetic variation on infection with HIV-1.
    McLaren PJ; Carrington M
    Nat Immunol; 2015 Jun; 16(6):577-83. PubMed ID: 25988890
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.